BCI
AMED

Brinker Capital Investments’s Amedisys AMED Stock Holding History

Brinker Capital Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-123
Closed -$21K – 322
2019
Q4 		$21K Buy
123
+63
+105% +$9.37K ﹤0.01% 499
2019
Q3 		$8K Buy
+60
New +$7.81K ﹤0.01% 588

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Brinker Capital Investments's AMED Position: Q1 2020 in Review

Brinker Capital Investments sold out of Amedisys (AMED) in Q1 2020, closing a stake of 123 shares — an estimated $21K sold.

Brinker Capital Investments first reported a position in AMED in Q3 2019 and held it in 2 quarters. The position peaked at $21K in Q4 2019. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • Brinker Capital Investments reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
  • Brinker Capital Investments sold 123 Amedisys shares in Q1 2020, an estimated $21K.
  • Brinker Capital Investments first reported a position in Amedisys in Q3 2019 and held it in 2 quarters.
  • Brinker Capital Investments's Amedisys position peaked at $21K in Q4 2019.
  • 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Brinker Capital Investments's 13F filing for Q1 2020, filed 13 May 2020.